Some US pharmacies and other vaccine providers are only offering the new COVID-19 booster shot from Pfizer (PFE) and BioNTech (BNTX) after a quality problem at a contract manufacturer caused a shortage of Moderna’s (MRNA) new booster shot, Peter Loftus of The Wall Street Journal reports. As a result, some pharmacies and other vaccine sits have canceled or stopped scheduling new appointments for people seeking the Moderna booster shot. A Moderna spokesman said the company anticipates resolving constraint issues in the coming days. Reference Link
Published first on TheFly
Read More on MRNA:
- MRNA, PFE, NVAX, BNTX: Pharma Stocks Shiver as the U.S. President Calls Pandemic ‘Over’
- Moderna Stock (NASDAQ:MRNA): Focus on Possibilities, Not Politics
- Pfizer vs. Moderna: Which Vaccine-Maker Has More Upside?
- Moderna Has One Over Pfizer/BioNTech – but It’s Nothing to Do With Patent Infringement
- Why Choosing Between Pfizer (NYSE:PFE) and Moderna Stocks Isn’t Easy for Investors